Results 111 to 120 of about 210,635 (269)

Hypogonadism in Cisgender Men Living With HIV: Prevalence, Clinical and Metabolic Features

Andrology, EarlyView.
ABSTRACT Background Hypogonadism is frequently observed in men living with human immunodeficiency virus (HIV), although its prevalence, etiology, and predictors remain incompletely understood. Objective To evaluate the prevalence of hypogonadism and its association with metabolic factors in men living with HIV (MLWH), on stable antiretroviral therapy ...
Felipe Augusto Azevedo Leao, Gabriel Cabreira Nunes, Manuela Almeida Ribeiro, Luiza Costa da Fonseca, Aline Cristina Miranda Marinho Costa, Mateus Rodrigues Westin, Unai Tupinambas, Milena Maria Moreira Guimaraes, Leticia Ferreira Gontijo Silveira   +8 more
wiley   +1 more source

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization

, 2010
SummaryObjectiveTo evaluate and compare the efficacy of microdose gonadotropin-releasing hormone (GnRH) agonist flare (MF) and GnRH antagonist/letrozole protocols in poor responders undergoing in vitro fertilization.Materials and MethodsA total of 94 ...
Razieh Dehghani Firouzabadi, Shahnaz Ahmadi, Robab Davar, Homa Oskouian   +3 more
core   +1 more source

Androgen Receptor Expression in Urothelial Bladder Cancer—A Systematic Review and Meta‐Analysis

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Bladder cancer is a globally prevalent malignancy with a marked male predominance. Over the past decade, the androgen receptor has been investigated as a potential contributor to bladder cancer pathophysiology. Androgen receptor expression is most commonly assessed via immunohistochemistry, but its association with pathological ...
Alex Buckby, Mandana Gholami, Matthew Hong, Michael O'Callaghan   +3 more
wiley   +1 more source

Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.

, 2006
Various studies have compared the efficacy of GnRH agonists (GnRH-a) and antagonists (GnRH-ant) for controlled ovarian stimulation (COS) in women undergoing IVF. Nevertheless, few data are available about the use of GnRH-ant in poor responders.
CONFORTI, SALVATORE, DE PLACIDO G, A. MOLLO, ALVIGGI C, MOLLO, ANTONIO, STRINA I, CLARIZIA R, STRINA, IDA, DE PLACIDO, GIUSEPPE, ALVIGGI, CARLO, CONFORTI S, Clarizia R., De Placido G., Strina I., Alviggi C., Mollo A., Conforti S.   +16 more
core   +1 more source

Genome‐wide association and interaction analysis for proliferative retinopathy in adults with type 2 diabetes born during famine: The DOLCE study in Ukraine

Acta Ophthalmologica, EarlyView.
Abstract Purpose Proliferative diabetic retinopathy (PDR) is one of the leading causes of blindness in working‐age adults. We have previously shown that the risk of PDR is significantly elevated in individuals with intrauterine exposure to famine. However, the genetic mechanisms mediating this association remain unknown.
Olena Fedotkina, Most Champa Begum, Xuan Tung Trinh, Turkuler Özgumus, Mikael Åkerlund, Peter Nilsson, Leticia Maria Spindola, Valeriya Lyssenko   +7 more
wiley   +1 more source

A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles

, 2012
To determine whether concentrations of oxidative stress markers of follicular fluid and serum are different in GnRH agonist protocol from GnRH antagonist ...
TÜRKÇÜOĞLU, ILGIN, ÖZEROL, ELİF, Celik, Ebru, Simsek, Yavuz, KARAER, ABDULLAH, Minareci, Yağmur, TANBEK, KEVSER, Kumbak, Banu, YILMAZ, ERCAN, Celik, Onder   +9 more
core   +1 more source

Prediction of pregnancy following transfer of in‐vitro produced embryos using recipient health records, accelerometer sensors and meteorological data in Australian dairy cows

Australian Veterinary Journal, EarlyView.
Embryo transfer (ET) in dairy cattle has long been used for the dissemination of elite genetics. However, achieving consistently high pregnancy rates remains a major challenge, particularly in high‐producing lactating dairy cows receiving in‐vitro produced (IVP) embryos.
AM Johnston, MD Greene, R Nevard, J House, S Rowe   +4 more
wiley   +1 more source

The serum hormone profiles of the patients with and without GnRH antagonist administration.

, 2016
L-rFSH w/ GnRH antagonist, the individuals who received GnRH antagonist in the follicular phase; L-rFSH w/o GnRH antagonist, the individuals who did not receive GnRH antagonist in the follicular phase. (A) Serum LH levels of the two groups; the LH levels
Shih-Chieh Huang (2622685), Shee-Uan Chen (149645), Hsing-Hua Lai (2622697), Yu-Wei Shih (2622700), Meng-Ju Lee (2622688), Huai-Ling Wang (2622691), Tzu-Hsuan Chuang (2622694)   +6 more
core   +1 more source

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

British Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral, Nicholas Monaco, Daniel I. Brierley, Monica Imbernon   +3 more
wiley   +1 more source